Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piers Blombery

Showing results (51-60 of 157) with videos related to

Pageof 16
Sort By:
BMC Medical Genomics|March 29, 2022
Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnosticsKenneth D Doig, Christopher G Love, Thomas Conway, et al.
Leukemia & Lymphoma|April 23, 2020
Detection of an IGH-<i>BRAF</i> fusion in a patient with BRAF Val600Glu negative hairy cell leukemiaElla R Thompson, Kenneth J C Lim, James A Kuzich, et al.
Leukemia|February 24, 2023
Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignanciesMaki Sakuma, Piers Blombery, Manja Meggendorfer, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 18, 2014
The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantationShaun Fleming, Simon J Harrison, Piers Blombery, et al.
BMC Bioinformatics|December 17, 2017
Canary: an atomic pipeline for clinical amplicon assaysKenneth D Doig, Jason Ellul, Andrew Fellowes, et al.
British Journal of Haematology|July 11, 2020
Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemiaGeorgina L Ryland, Allison Barraclough, Chun Yew Fong, et al.
Journal of Clinical Pathology|August 13, 2017
Incidental detection of germline variants of potential clinical significance by massively parallel sequencing in haematological malignanciesCostas K Yannakou, Kate Jones, Georgina L Ryland, et al.
The Australasian Journal of Dermatology|October 5, 2022
VEXAS syndrome: A dermatological perspectiveJacqueline K Nguyen, David Routledge, Carrie van Der Weyden, et al.
Biodata Mining|October 30, 2025
Using artificial intelligence (AI) to model clinical variant reporting for next generation sequencing (NGS) oncology assaysKenneth D Doig, Rashindrie Perera, Yamuna Kankanige, et al.
Histopathology|October 15, 2024
Closing the gap between biology and classification in splenic B-cell lymphomasPiers Blombery, Daphne de Jong, Judith A Ferry, et al.
Pageof 16

Showing results (51-60 of 157) with videos related to

Sort By:
Pageof 16
BMC Medical Genomics|March 29, 2022
Findings from precision oncology in the clinic: rare, novel variants are a significant contributor to scaling molecular diagnosticsKenneth D Doig, Christopher G Love, Thomas Conway, et al.
Leukemia & Lymphoma|April 23, 2020
Detection of an IGH-<i>BRAF</i> fusion in a patient with BRAF Val600Glu negative hairy cell leukemiaElla R Thompson, Kenneth J C Lim, James A Kuzich, et al.
Leukemia|February 24, 2023
Novel causative variants of VEXAS in UBA1 detected through whole genome transcriptome sequencing in a large cohort of hematological malignanciesMaki Sakuma, Piers Blombery, Manja Meggendorfer, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 18, 2014
The choice of multiple myeloma induction therapy affects the frequency and severity of oral mucositis after melphalan-based autologous stem cell transplantationShaun Fleming, Simon J Harrison, Piers Blombery, et al.
BMC Bioinformatics|December 17, 2017
Canary: an atomic pipeline for clinical amplicon assaysKenneth D Doig, Jason Ellul, Andrew Fellowes, et al.
British Journal of Haematology|July 11, 2020
Inotuzumab ozogamicin resistance associated with a novel CD22 truncating mutation in a case of B-acute lymphoblastic leukaemiaGeorgina L Ryland, Allison Barraclough, Chun Yew Fong, et al.
Journal of Clinical Pathology|August 13, 2017
Incidental detection of germline variants of potential clinical significance by massively parallel sequencing in haematological malignanciesCostas K Yannakou, Kate Jones, Georgina L Ryland, et al.
The Australasian Journal of Dermatology|October 5, 2022
VEXAS syndrome: A dermatological perspectiveJacqueline K Nguyen, David Routledge, Carrie van Der Weyden, et al.
Biodata Mining|October 30, 2025
Using artificial intelligence (AI) to model clinical variant reporting for next generation sequencing (NGS) oncology assaysKenneth D Doig, Rashindrie Perera, Yamuna Kankanige, et al.
Histopathology|October 15, 2024
Closing the gap between biology and classification in splenic B-cell lymphomasPiers Blombery, Daphne de Jong, Judith A Ferry, et al.
Pageof 16